|
1
|
Dimaras H, Corson TW, Cobrinik D, White A,
Zhao J, Munier FL, Abramson DH, Shields CL and Chantada GL:
Retinoblastoma. Nat Rev Dis Primers. 1:150212015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Giacinti C and Giordano A: RB and cell
cycle progression. Oncogene. 25:5220–5227. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Vermeulen K, Van Bockstaele DR and
Berneman ZN: The cell cycle: A review of regulation, deregulation
and therapeutic targets in cancer. Cell Prolif. 36:131–149. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Park SJ, Woo SJ and Park KH: Incidence of
retinoblastoma and survival rate of retinoblastoma patients in
Korea using the Korean national cancer registry database
(1993–2010). Invest Ophthalmol Vis Sci. 55:2816–2821. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jung EH, Kim JH, Kim JY, Jo DH and Yu YS:
Outcomes of proton beam radiation therapy for retinoblastoma with
vitreous seeds. J Pediatr Hematol Oncol. 40:569–573. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Moon J, Choi SH, Lee MJ, Jo DH, Park UC,
Yoon SO, Woo SJ and Oh JY: Ocular surface complications of local
anticancer drugs for treatment of ocular tumors. Ocul Surf.
19:16–30. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Karlseder J, Rotheneder H and
Wintersberger E: Interaction of Sp1 with the growth- and cell
cycle-regulated transcription factor E2F. Mol Cell Biol.
16:1659–1667. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lin SY, Black AR, Kostic D, Pajovic S,
Hoover CN and Azizkhan JC: Cell cycle-regulated association of E2F1
and Sp1 is related to their functional interaction. Mol Cell Biol.
16:1668–1675. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rotheneder H, Geymayer S and Haidweger E:
Transcription factors of the Sp1 family: Interaction with E2F and
regulation of the murine thymidine kinase promoter. J Mol Biol.
293:1005–1015. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dong S, Kojima T, Shiraiwa M, Méchin MC,
Chavanas S, Serre G, Simon M, Kawada A and Takahara H: Regulation
of the expression of peptidylarginine deiminase type II gene
(PADI2) in human keratinocytes involves Sp1 and Sp3 transcription
factors. J Invest Dermatol. 124:1026–1033. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nagai T, Matsueda Y, Tomita T, Yoshikawa H
and Hirohata S: The expression of mRNA for peptidylarginine
deiminase type 2 and type 4 in bone marrow CD34+ cells in
rheumatoid arthritis. Clin Exp Rheumatol. 36:248–253.
2018.PubMed/NCBI
|
|
12
|
Ishigami A, Ohsawa T, Asaga H, Akiyama K,
Kuramoto M and Maruyama N: Human peptidylarginine deiminase type
II: Molecular cloning, gene organization, and expression in human
skin. Arch Biochem Biophys. 407:25–31. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang H, Xu B, Zhang X, Zheng Y, Zhao Y and
Chang X: PADI2 gene confers susceptibility to breast cancer and
plays tumorigenic role via ACSL4, BINC3 and CA9 signaling. Cancer
Cell Int. 16:612016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Clancy KW, Russell AM, Subramanian V,
Nguyen H, Qian Y, Campbell RM and Thompson PR:
Citrullination/methylation crosstalk on histone H3 regulates
ER-target gene transcription. ACS Chem Biol. 12:1691–1702. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu L, Zhang Z, Zhang G, Wang T, Ma Y and
Guo W: Down-regulation of PADI2 prevents proliferation and
epithelial-mesenchymal transition in ovarian cancer through
inhibiting JAK2/STAT3 pathway in vitro and in vivo, alone or in
combination with Olaparib. J Transl Med. 18:3572020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sharma P, Lioutas A, Fernandez-Fuentes N,
Quilez J, Carbonell-Caballero J, Wright RHG, Vona CD, Dily FL,
Schüller R, Eick D, et al: Arginine citrullination at the
C-terminal domain controls RNA polymerase II transcription. Mol
Cell. 73:84–96. e872019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang L, Song G, Zhang X, Feng T, Pan J,
Chen W, Yang M, Bai X, Pang Y, Yu J, et al: PADI2-mediated
citrullination promotes prostate cancer progression. Cancer Res.
77:5755–5768. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Guertin MJ, Zhang X, Anguish L, Kim S,
Varticovski L, Lis JT, Hager GL and Coonrod SA: Targeted H3R26
deimination specifically facilitates estrogen receptor binding by
modifying nucleosome structure. PLoS Genet. 10:e10046132014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Horibata S, Rogers KE, Sadegh D, Anguish
LJ, McElwee JL, Shah P, Thompson PR and Coonrod SA: Role of
peptidylarginine deiminase 2 (PAD2) in mammary carcinoma cell
migration. BMC Cancer. 17:3782017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xue T, Liu X, Zhang M, Qiukai E, Liu S,
Zou M, Li Y, Ma Z, Han Y, Thompson P and Zhang X: PADI2-catalyzed
MEK1 citrullination activates ERK1/2 and promotes IGF2BP1-mediated
SOX2 mRNA stability in endometrial cancer. Adv Sci (Weinh).
8:20028312021. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jo DH and Kim JH, Cho CS, Cho YL, Jun HO,
Yu YS, Min JK and Kim JH: STAT3 inhibition suppresses proliferation
of retinoblastoma through down-regulation of positive feedback loop
of STAT3/miR-17-92 clusters. Oncotarget. 5:11513–11525. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jo DH, Lee S, Bak E, Cho CS, Han YT, Kim
K, Suh YG and Kim JH: Antitumor activity of novel signal transducer
and activator of transcription 3 inhibitors on retinoblastoma. Mol
Pharmacol. 100:63–72. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cho CS, Jo DH and Kim JH and Kim JH:
Establishment and characterization of carboplatin-resistant
retinoblastoma cell lines. Mol Cells. 45:729–737. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Khokhlova ON, Tukhovskaya EA, Kravchenko
IN, Sadovnikova ES, Pakhomova IA, Kalabina EA, Lobanov AV,
Shaykhutdinova ER, Ismailova AM and Murashev AN: Using
tiletamine-zolazepam-xylazine anesthesia compared to
CO(2)-inhalation for terminal clinical chemistry, hematology, and
coagulation analysis in mice. J Pharmacol Toxicol Methods.
84:11–19. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jo DH, Lee K and Kim JH, Jun HO, Kim Y,
Cho YL, Yu YS, Min JK and Kim JH: L1 increases adhesion-mediated
proliferation and chemoresistance of retinoblastoma. Oncotarget.
8:15441–15452. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jang H, Jo DH, Cho CS, Shin JH, Seo JH, Yu
G, Gopalappa R, Kim D, Cho SR, Kim JH and Kim HH: Application of
prime editing to the correction of mutations and phenotypes in
adult mice with liver and eye diseases. Nat Biomed Eng. 6:181–194.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xu H, Koch P, Chen M, Lau A, Reid DM and
Forrester JV: A clinical grading system for retinal inflammation in
the chronic model of experimental autoimmune uveoretinitis using
digital fundus images. Exp Eye Res. 87:319–326. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen M, Copland DA, Zhao J, Liu J,
Forrester JV, Dick AD and Xu H: Persistent inflammation subverts
thrombospondin-1-induced regulation of retinal angiogenesis and is
driven by CCR2 ligation. Am J Pathol. 180:235–245. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Testa JR and Bellacosa A: AKT plays a
central role in tumorigenesis. Proc Natl Acad Sci USA.
98:10983–10985. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liu W, Bagaitkar J and Watabe K: Roles of
AKT signal in breast cancer. Front Biosci. 12:4011–4019. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shukla S, Maclennan GT, Hartman DJ, Fu P,
Resnick MI and Gupta S: Activation of PI3K-Akt signaling pathway
promotes prostate cancer cell invasion. Int J Cancer.
121:1424–1432. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Fu R, Yang P, Wu HL, Li ZW and Li ZY:
GRP78 secreted by colon cancer cells facilitates cell proliferation
via PI3K/Akt signaling. Asian Pac J Cancer Prev. 15:7245–7249.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yan X, Wu S, Liu Q and Zhang J: RRS1
promotes retinoblastoma cell proliferation and invasion via
activating the AKT/mTOR signaling pathway. Biomed Res Int.
2020:24204372020. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang H, Zhang P, Long C, Ma X, Huang H,
Kuang X, Du H, Tang H, Ling X and Ning J: m(6)A methyltransferase
METTL3 promotes retinoblastoma progression via PI3K/AKT/mTOR
pathway. J Cell Mol Med. 24:12368–12378. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Bao XY, Sun M, Peng TT and Han DM: TRIB3
promotes proliferation, migration, and invasion of retinoblastoma
cells by activating the AKT/mTOR signaling pathway. Cancer Biomark.
31:307–315. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Diefenbach J and Bürkle A: Introduction to
poly(ADP-ribose) metabolism. Cell Mol Life Sci. 62:721–730. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Creel DJ: Electroretinograms. Handb Clin
Neurol. 160:481–493. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Monreal MT, Rebak AS, Massarenti L, Mondal
S, Šenolt L, Ødum N, Nielsen ML, Thompson PR, Nielsen CH and
Damgaard D: Applicability of small-molecule inhibitors in the study
of peptidyl arginine deiminase 2 (PAD2) and PAD4. Front Immunol.
12:7162502021. View Article : Google Scholar : PubMed/NCBI
|
